Dr. Maseras takes part in the meeting Perlas Retina 2017

Medical content revised by - Last revision 02/03/2017
Dr. Maseras takes part in the meeting Perlas Retina 2017

The 6th edition of the medical meeting Perlas Retina 2017 organized by Novartis and Alcon is held today, March 2nd in Madrid, and will gather renowned ophthalmologist from all over Spain.

Perlas Retina is an ophthalmology reference event that focuses on retinal diseases. From clinical cases, experiences related to surgical and medical management of these diseases are discussed and commented.

In Spain, an estimated 2 million people suffer from diseases that affect the retina. Some of these diseases are among the leading blindness causes in developed countries.

Nevertheless, the progress brought by new intraoperative visualization systems and developments in medical technology have substantially improved vitreoretinal surgery procedures.

Discussion topics

In this occasion, a series of complex clinical cases and complication that can arise both during and after the interventions will be presented. The aim is to make participants draw relevant conclusions on the topic with the expert help from panelists.

The discussion will also analyse how new technologies applied to surgical microscopes can be helpful during vitreoretinal surgeries.

Dr. Xavier Maseras, member of ICR Retina Department will take part as a panelist in the meeting, which will provide participants with a series of tools for everyday use in clinical practice.

Post your comment

In accordance with the provisions of the General Data Protection Regulation (REGULATION (EU) 2016/679), the following information about the processing of personal data is disclosed to you.

Responsible: Institut Català de la Retina, S.L., Institut Català de Cirurgia refractiva, S.L. (from now on ICR)

Representative of Data Protection Contact: C/Pau Alcover nº 67 08017 Barcelona – rgpd@icrcat.com

Aim: The purpose of the treatment is to manage the information you provide us and after having your consent, publish the testimonial on our website.

Legitimization: The legal basis for the present treatment is the request made by you and having your consent.

Recipients: The recipients of the information are the departments and delegations in which ICR is organized, in part or in its entirety. It will not be communicated to third parties.

Rights: At any time, you can exercise your rights of access, rectification, deletion, opposition, limitation of treatment and / or portability of data by writing to the RPD Representative of Data Protection at the address provided in contact. You can also revoke consents to other treatments. You can also request more information from the RPD about the treatments performed.
In the event that you consider that your rights have been violated, you can submit a claim to the competent Data Protection Control Authority.

For all purposes, the user accepts that the opinion expressed will be exclusively his /her responsibility. The user assumes under his / her exclusive responsibility the damages or harms that may derive from it.
ICR will not be responsible for the accuracy, quality, reliability, correctness, morality and legality of the data, information or opinions published by users.
ICR reserves the right not to publish all opinions of users.
The user is solely responsible of his /her username. ICR will not be responsible for the illegal use or for illicit purposes that other users can make of this user name.

Preservation: The collected data will be kept during the time required for the requested management, for at most 30 days.

ICR Ganduxer Headquarters

c/Ganduxer,117
08022 Barcelona

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona

ICR Terrassa

C. del Nord, 77
08221 Terrassa

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona
This website uses cookies in order to collect statistical information regarding navigation. If you keep on surfing this website, it shall be deemed to have acknowledged its use. More information.